Contact us
Research Partnerships

Built for practices ready to grow through research

Iterative Health’s site-serving model is designed for the long-term success of elite community-based practices, expanding access to novel therapies for their unique patient populations while building a durable ancillary service line. Our infrastructure includes best-in-class studies, staff hiring and development, and centralized operational support.

Join our network

Where leading research sites drive breakthroughs

A performance-driven network advancing GI, Hepatology, Obesity, and Cardiology research

  • Gastroenterology

    Charles C. Owen, Jr., MD,
    MBA, FACP, AGAF

    VP, GI Medical
    Iterative Health

  • Hepatology & Obesity

    Nadege Gunn, MD, CPI,
    DABOM, FAASLD

    Chief Medical Officer
    Iterative Health

  • Cardiology

    Samin K. Sharma, MD,
    FACC, MSCAI

    Honorary Chair, Interventional Cardiology
    Iterative Health

A steady pipeline of cutting-edge studies
Our in-house business development team secures sponsor and CRO relationships at the network level, giving partner sites reliable access to premium-budget studies backed by a track record for fast enrollment.

Centralized operations without overburdening clinical care
We believe sites are the backbone of trials and designed a centralized operating model with deep, specialized knowledge across GI, hepatology, and cardiology research. Site support spans coordinator hiring and training, site feasibility and activation, regulatory and quality, AI-powered patient recruitment, and accounting, so research can grow without draining clinical staff.

Innovative care that grows the practice
By taking on the cost, risk, and operational responsibility to grow a profitable research ancillary embedded into everyday care, physicians are able to offer research as a treatment option that improves patient outcomes and access to the next generation of care.

Strategic Partners

We’re proud to partner with three leading provider networks, GI Alliance, One GI, and US Heart & Vascular (USHV), to expand access to clinical trials across community-based practices and accelerate the advancement of new therapies for patients.

Where is your practice today?

New, starting
from scratch


We establish research programs from the ground up, hiring and training the coordinator and sourcing studies tailored to the practice’s patient population on a defined timeline.

  • Research-readiness in 3 months 
  • First cutting-edge trial in 6 months
  • De-risked plan to ramp to first $1M in revenue potential
Start building

Running trails,
ready to grow


We help established programs scale past their operational limits with a specialized team, expanded study pipeline, and dedicated growth
support. Industry-leading performance across our sites includes:

  • 2X faster site activation 
  • 3X greater enrollment rates
Unlock growth

Building research
across a network


We partner with provider groups and MSOs to build and scale research network-wide through a centralized operating model, turning it into a growing service line for every physician in the organization.

  • Partnership model maintains clinical independence
  • Centralized research operational backbone established in 120 days
Partner with us

AI-Enabled Operational Backbone

Unlike traditional CROs or SMOs, we manage the day-to-day operations
of research on behalf of the practice, supported by AI-enabled tools

Finance and budgets

Financial management and budgeting handled centrally

Legal support

Legal review and support for study agreements

Study start-up

Site feasibility through activation

Regulatory management

Regulatory and quality oversight

Sponsor and CRO communication

Direct communication and resolution management

Study Pipeline Growth

Ongoing sourcing and contracting of new study opportunities

AI-powered patient pre-screening

Technology exclusive to the Iterative Health Site Network demonstrates a 40% uplift in patient randomizations and relieves thousands of hours of chart review.

Hear from our PI Leadership
and Scientific Advisors

Executives highlight the support and performance that set Iterative Health apart
G. Aaron DuVall, MDTyler Research InstitutePrincipal Investigator

“Scaling community research requires more than clinical expertise and physician dedication. This collaborative approach [with Iterative Health] emphasizes site performance, growth, and sustainability, allowing TRI to maintain focus on delivering strong clinical outcomes and patient-centered research.”

Ziad Younes, MDOne GIPrincipal Investigator

“Iterative Health has been a trusted partner to our site for several years, and I’ve seen firsthand the depth of their support and expertise.”

David Rubin, MDUChicagoChief, Gastroenterology

“By improving research with more reliable and standardized assessments, we can accelerate the development of new therapies and generate better data on their efficacy, ultimately enabling providers to make more informed treatment decisions.”

Casey Chapman, MDGI AllianceChief Medical Officer

“By combining GIA’s clinical depth with Iterative Health’s innovative infrastructure, we are enabling more physicians and their patients to participate in cutting-edge clinical trials without leaving their communities.”

Thomas Waggoner, DO,
FACC, FSCAI, FSVM, RPVIUS Heart & VascularPrincipal Investigator

“Innovation in cardiovascular medicine shouldn’t be limited to a few academic centers. By expanding community-based research across USHV, we’re ensuring more patients have access to clinical trials and breakthrough therapies close to home, where trusted relationships with their physicians already exist.”

Resources and insights in clinical research

Learn from experts, case studies, and best practices that are driving faster, more efficient,
and patient-focused clinical trials in GI, Hepatology, Obesity, and Cardiology.

A Closer Look at Dr. DuVall’s Clinical Leader Article on Accelerating Clinical Trials

Dr. DuVall outlines how specialized, community-based research sites reduce study activation time, expand patient access, and improve trial execution by embedding research directly into everyday care settings, demonstrating why integrated clinics are critical to delivering faster, higher-quality clinical research in today’s increasingly complex trial landscape.

Learn More

Driving Operational Excellence in Ambulatory Surgery Centers: How Iterative Health Accelerates Clinical Trial Success

Iterative Health helps Ambulatory Surgery Centers accelerate clinical trials by streamlining operations, improving recruitment, and ensuring compliance. With AI tools and hands-on support, ASCs activate sites faster, retain patients, and meet milestones efficiently, enabling quicker delivery of novel therapies without overburdening teams.

Learn More

Beyond Academic Walls: The Case for Community-Based Cardiovascular Trials

Writing in International Clinical Trials, Dr. Thomas Waggoner argues cardiovascular research relies too heavily on academic centers, narrowing who the evidence represents. With faster enrollment, more representative populations, and care delivered where patients already receive it, he makes the case for community cardiology practices as genuine, well-supported research partners for sponsors.

Learn More